These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15219134)

  • 1. [Added to conventional therapy, what does mistletoe extract contribute in breast carcinoma].
    MMW Fortschr Med; 2004 Mar; 146(13):58. PubMed ID: 15219134
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2006 Nov; 11(11):485-95. PubMed ID: 17182361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Forsch Komplementmed; 2006 Oct; 13(5):285-92. PubMed ID: 17057389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iscador--mistletoe extract for cancer treatment. Documentation No. 10].
    Schweiz Rundsch Med Prax; 1988 Jan; 77(4):69-74. PubMed ID: 3279479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibilities and limits of mistletoe therapy in cancer patients].
    Hoffmann J
    Arch Gynecol Obstet; 1987; 242(1-4):257-60. PubMed ID: 3688952
    [No Abstract]   [Full Text] [Related]  

  • 6. [Problems of randomized studies in complementary medicine demonstrated in a study on mistletoe treatment of patients with breast cancer].
    Gerhard I; Abel U; Loewe-Mesch A; Huppmann S; Kuehn JJ
    Forsch Komplementarmed Klass Naturheilkd; 2004 Jun; 11(3):150-7. PubMed ID: 15249749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent response of small cell lung cancer to an extract of mistletoe and homoeopathic treatment.
    Bradley GW; Clover A
    Thorax; 1989 Dec; 44(12):1047-8. PubMed ID: 2559483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of mistletoe therapy in carcinoma patients].
    Rostock M; Unger C
    Internist (Berl); 1998 Dec; 39(12):1294-5. PubMed ID: 10198836
    [No Abstract]   [Full Text] [Related]  

  • 9. Retrolective, comparative, epidemiological cohort study with parallel groups design for evaluation of efficacy and safety of drugs with "well-established use".
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():23-9. PubMed ID: 15353899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.
    Kaegi E
    CMAJ; 1998 May; 158(9):1157-9. PubMed ID: 9597967
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mistletoe in immunology and the clinic (short review).
    Stein GM; Schietzel M; Büssing A
    Anticancer Res; 1998; 18(5A):3247-9. PubMed ID: 9858890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mistletoe therapy in cancer treatment: pros and cons].
    Wiebelitz KR; Beer AM; Heinrich B
    MMW Fortschr Med; 2009 Nov; 151(46):30-1. PubMed ID: 20043390
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of ML-1 standardized mistletoe extract on the quality of life in head and neck cancer patients].
    Steuer-Vogt MK; Bonkowsky V; Scholz M; Fauser C; Licht K; Ambrosch P
    HNO; 2006 Apr; 54(4):277-86. PubMed ID: 16132877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anthroposophy. Mistletoe preparations: a cancer inhibiting wonder drug?].
    Arm F
    Krankenpfl Soins Infirm; 1989 May; 82(5):18-21. PubMed ID: 2747189
    [No Abstract]   [Full Text] [Related]  

  • 16. Mistletoe lectins: telomerase inhibitors in alternative cancer therapy.
    Li SS
    Drug Discov Today; 2002 Sep; 7(17):896-7. PubMed ID: 12546929
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.
    Grossarth-Maticek R; Ziegler R
    Arzneimittelforschung; 2007; 57(10):665-78. PubMed ID: 18074761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients are talking about ... Iscador (mistletoe).
    Decker G
    Clin J Oncol Nurs; 2001; 5(4):183-4. PubMed ID: 12690624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood and tissue eosinophilia, mistletoe lectin antibodies and quality of life in a breast cancer patient undergoing intratumoral and subcutaneous mistletoe therapy].
    Kröz M; Schad F; Matthes B; Pickartz H; Girke M
    Forsch Komplementarmed Klass Naturheilkd; 2002 Jun; 9(3):160-7. PubMed ID: 12119512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of DNA repair in lymphocytes of breast cancer patients treated with Viscum album extract (Iscador).
    Kovacs E; Hajto T; Hostanska K
    Eur J Cancer; 1991; 27(12):1672-6. PubMed ID: 1782081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.